AI assistant
DEXCOM INC — Director's Dealing 2014
Dec 16, 2014
30198_dirs_2014-12-16_8bf72da4-5d2c-4bd5-81a5-4a6e116ce62f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-12-12
Reporting Person: LISTER JOHN (Sr. VP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-12 | Common Stock | S | 1329.0 | $53.5443 | Disposed | 106018 | Direct |
| 2014-12-12 | Common Stock | M | 1750.0 | $4.58 | Acquired | 107768 | Direct |
| 2014-12-12 | Common Stock | S | 1750.0 | $53.5479 | Disposed | 106018 | Direct |
| 2014-12-15 | Common Stock | M | 4000.0 | $4.58 | Acquired | 110018 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-15 | Incentive Stock Option (right to buy) | $4.58 | M | 4000.0 | Disposed | 2019-05-19 | Common Stock (4000) | Direct |
| 2014-12-12 | Non-Qualified Stock Option (right to buy) | $4.58 | M | 1750.0 | Disposed | 2019-05-19 | Common Stock (1750) | Direct |
Footnotes
F1: On December 11, 2013, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $53.15 to $53.98. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Included in this number are 88,021 unvested restricted stock units, 65,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 17,500 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 5,521 of which were granted on March 8, 2012 and shall vest through March 8, 2015.
F4: This transaction was executed in multiple trades at prices ranging from $53.25 to $54.03. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.